"Ask the Expert” features answers by our experts to your clinical questions. Question: Have there been any studies proving the efficacy of post-transplant rituximab treatment for lymphoma?Answer: Initially, a benefit from post–transplant maintenance rituximab had been suggested by small phase II studies, but, as now confirmed by results from the CORAL study by GELA (Groupe d'Etude des Lymphomes de l'Adulte), which looked at rituximab-ICE (ifosfamide, carboplatin, etoposide) or rituximab-DHAP (dexamethasone,...